Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Product/Service, Trade Show, Webcast

Geron Announces September Investor Conference Presentation Webcasts


Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., Geron's Chairman and Chief Executive Officer, is scheduled to present at the following investor conferences:

A live webcast of each presentation will be available through the Investor Relations section of Geron's website under Events. Following the presentations, the webcasts will be archived and available for replay for a period of 30 days.

About Geron

Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The Company currently is conducting two Phase 3 clinical trials: IMerge in lower risk myelodysplastic syndromes and IMpactMF in refractory myelofibrosis. For more information about Geron, visit www.geron.com.


These press releases may also interest you

at 10:05
Regulated Information ? Inside Information ? UCB, a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that they were unable to complete review of the Biologics License...

at 09:57
Throughout the unprecedented COVID-19 pandemic response, the Government of Canada has been providing significant support to provinces and territories. The Minister of Public Safety and Emergency Preparedness, the Honourable Bill Blair, confirmed that...

at 07:00
Transplant Québec is thrilled about the joint commitment announced yesterday at the Forum Québec by the provincial government and the three opposition parties. The announcement comes on the eve of World Organ Donation Day and in the wake of the first...

at 05:30
Organized by American Vein and Lymphatic Society, the AVLS 35th Annual Congress, 2021, was held from Thursday, October 7, 2021, through Sunday, October 10, 2021, at the Gaylord Rockies Resort & Convention Center, Denver, Colorado. The conference was...

15 oct 2021
Helix BioPharma Corp. ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announced today that it anticipates the filing of its annual financial...

15 oct 2021
The Centers for Medicare and Medicaid Services (CMS) released its annual quality rankings. For the 2022 plan year, Network Health earned a 5 out of 5-Star Rating from CMS for its Medicare Advantage PPO plans. This is Medicare's highest possible...



News published on 1 september 2021 at 16:35 and distributed by: